CN Stock MarketDetailed Quotes

300026 Tianjin Chase Sun Pharmaceutical

Watchlist

3.93
+0.12+3.15%

Market Closed Dec 27 15:00 CST

11.81BMarket Cap71.45P/E (TTM)

Tianjin Chase Sun Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tianjin Chase Sun Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 6.511B	--
--	2024/FY	-- / 6.194B	--
--	2023/FY	6.127B / 6.672B	--
--	2022/FY	6.650B / 6.758B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 6.511B--

--2024/FY-- / 6.194B--

--2023/FY6.127B / 6.672B--

--2022/FY6.650B / 6.758B--

--------

Unlock Free Earnings Estimates

Open Account

Tianjin Chase Sun Pharmaceutical Earnings Reports

Hongri Pharmaceutical: Report for the third quarter of 2024

Oct 24 12:00 ET

Hongri Pharmaceutical: 2024 Semi-Annual Report

Aug 29 12:00 ET

Hongri Pharmaceutical: 2024 Semi-Annual Report Summary

Aug 29 12:00 ET

Tianjin Chase Sun Pharmaceutical: 2024 First Quarter Report

Apr 25 12:00 ET

Analyst Rating

Updated: Dec 29, 2024

Buy

Strong Buy
0.00%
Buy
100.00%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall

No Data

Investment Theme

Traditional Chinese Medicine Concept